Your browser doesn't support javascript.
loading
Characterising ALS disease progression according to El Escorial and Gold Coast criteria.
de Jongh, Adriaan D; Braun, Nathalie; Weber, Markus; van Es, Michael A; Masrori, Pegah; Veldink, Jan H; van Damme, Philip; van den Berg, Leonard H; van Eijk, Ruben P A.
Afiliação
  • de Jongh AD; Department of Neurology, University Medical Center Utrecht Brain Center Rudolf Magnus, Utrecht, The Netherlands.
  • Braun N; Neuromuscular Diseases Unit/ALS Clinic, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Weber M; Neuromuscular Diseases Unit/ALS Clinic, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • van Es MA; Department of Neurology, University Medical Center Utrecht Brain Center Rudolf Magnus, Utrecht, The Netherlands.
  • Masrori P; Department of Neurosciences, Laboratory for Neurobiology, KU Leuven and Center for Brain & Disease Research, VIB, Leuven Brain Institute, Leuven, Belgium.
  • Veldink JH; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
  • van Damme P; Department of Neurology, University Medical Center Utrecht Brain Center Rudolf Magnus, Utrecht, The Netherlands.
  • van den Berg LH; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
  • van Eijk RPA; Department of Neurology, University Medical Center Utrecht Brain Center Rudolf Magnus, Utrecht, The Netherlands.
J Neurol Neurosurg Psychiatry ; 93(8): 865-870, 2022 08.
Article em En | MEDLINE | ID: mdl-35654584

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Idioma: En Ano de publicação: 2022 Tipo de documento: Article